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Background and novelty
Antibody-dependent cellular cytotoxicity (ADCC) is one
important mode of action for therapeutic mAbs in the
field of oncology. It is strongly dependent on the glycan
pattern of the Fc N-glycan: low core-fucose levels (= high
non-fucose levels) typically result in an increased ADCC.
There are several options to reach high non-fucose levels
like the selection of the right host that expresses the
desired pattern, in vitro glycosylation, use of glycosylation
inhibitors, alteration of process parameters and generat-
ing glycosylation mutants with modified glycan synthesis
activities by cell line engineering.
Within Roche Pharma we are working with CHO cell
lines designed to produce therapeutic antibodies based
on the GlycArt system. These cell lines contain in addi-
tion to the recombinant gene for the therapeutic mono-
clonal antibody (mAb), also recombinant genes for two
glycosyltransferases, N-acetylglucosaminyltransferase-III
(GntIII) and mannosidase-II (ManII). As a result the
CHO cells produce antibodies with a modified glycosyla-
tion structure characterized by a low-fucose Fc part. The
selection system for the two glycosylation enzymes is
based on the use of puromycin whereas for the mAB
MSX is used.
Experimental approach
During the scale up of a cell culture process for a late
stage project we observed that the cell age might influ-
ence the non-fucose level and thus the ADCC of the
recombinant monoclonal antibody negatively. To ensure
a high product quality even at a high cell age we investi-
gated the correlation between cell age and non-fucose
level in more detail by identifying underlying mechan-
isms with focus on the glycosylation enzymes GntIII
and ManII that are overexpressed in this cell line. For
this purpose a method was established in collaboration
with Roche Diagnostics to quantify the gene expression
level of the glycosylation enzymes using RT-qPCR based
on the RealTime ready technology.
At the beginning of the project a cell age study was con-
ducted using shake flasks in serial culture mode to gener-
ate cells with different and especially high cell age. The
cells were cultured under different selective conditions:
(1) a combination of puromyin and MSX (2) only with
puromycin, (3) only with MSX and (4) without selective
pressure. Cells were frozen at different time points up to a
cell age of 97 days. Afterwards a fed-batch experiment
with all cell banks of different cell age and selective condi-
tions simultaneously was run. The fed-batch experiment
was conducted with our in-house developed robotic cell
culture system that enables a fully automated workflow
based on shaken multiwell plates [1].
Results and discussion
The data from the cell age study verified the finding that
the cell age negatively influences the non-fucose levels.
We could show that the combination of puromycin and
MSX stabilizes the non-fucose level at a high cell age up
to 110 days whereas the use of puromycin or MSX
alone provides only a slight stabilization. The cultivation
without selective pressure resulted in the lowest non-
fucose levels. Running the automated fed-batch experi-
ment we could verify the results from the cell age study
and we could also show that the results from the auto-
mated system are predictive for a bioreactor. To under-
stand the role of the glycosylation enzymes in this
context we quantified the gene transcription level of the
recombinant glycosylation enzymes ManII and GnTIII.
Since a suitable RT-qPCR method was not available we
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ready technology in collaboration with colleagues from
Roche Diagnostics.
The mRNA levels of GntIII and ManII were measured
over the course of the seed train study (shake flask)
using the developed RT-qPCR method and related to
corresponding glycosylation data of the mAb at the end
of the fed-batch production run in our cell culture
robotics facility (Figure 1). At high cell age a direct cor-
relation between non-fucose level and GntIII gene tran-
scription level could be shown, whereby the highest
mRNA levels were obtained for the cultures that used
the combination of puromycin and MSX. The absence
of selective pressure resulted in the lowest GntIII
mRNA levels and thus the lowest non-fucose levels. The
correlation between ManII mRNA and non-fucose level
is not as clear as seen for the GntIII however the stabi-
lizing effect of selective pressure could be shown.
The stabilizing effect of selective pressure on non-
fucose level as well as the direct correlation between
GntIII mRNA and non-fucose levels could be confirmed
with a second recombinant cell line.
Based on the results of this study cultivation recom-
mendations regarding the in vitro cell age and the selec-
tion pressure for the seed- and inoculum-train of a
production process could be provided. Also a direct cor-
relation between selective pressure addition, GntIII and
ManII transcription level and the non-fucose level for
cells with a high cell age could be identified. The results
of this study provide insight into the mechanisms of gly-
cosylation of recombinant GntIII and ManII cell lines.
Data from the robotics experiment closely mirrored the
production scale.
Furthermore, a high throughput RT-qPCR method
was developed based on the RealTime ready technology
to monitor gene transcription based on CHO cells that
was not previously available. This platform will be
further expanded to be applied to more CHO genes.
Acknowledgements
We would like to thank all colleagues who contributed to this work, namely M.
Baumeister, S. Eppler, K. Graf, M. Hechler, A. Höfer, H.G. Ihlenfeldt, O. Kaiser, N.
Matthei, K.C. Nabo H. Walch and M. Wiesinger from Roche Diagnostics, K.
Diepold, A. Esterl, J. Gassner, M. Gräf, M. Haberger, J. Hoffmann, M. Leonhardt, C.
Musmann, G. Pechmann, M. Radtke, F. Schache, C. Schuster, A. Strauch, M.
Weichert and F. Weissbecker from Roche Pharma Biotech Development
Fermentation and our management, J. Gabelsberger and W. Kuhne for their
continuous support and helpful contributions.
Published: 14 December 2015
Reference
1. Markert S, Musmann C, Joeris K: Development and application of an
automated, multiwell plate based screening system for suspension cell
culture. BMC Proc 2013, 7(Suppl 6):P113.
doi:10.1186/1753-6561-9-S9-O5
Cite this article as: Markert et al.: Non-fucose level as a function of
glycoenzyme transcription in a glycoengineered CHO cell line. BMC
Proceedings 2015 9(Suppl 9):O5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Figure 1 (A) GntIII gene transcription data; (B) ManII gene transcription data; (C) Non-fucose level. For (C): Colored squares represent
data from automated cell culture system and black squares from 10.000 L bioreactor.
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